)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Arovella Therapeutics
Arovella Therapeutics (ALA) investor relations material
Arovella Therapeutics Q2 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 TU earnings summary22 Jan, 2026
Executive summary
Filed IND application for ALA-101 with the U.S. FDA, advancing toward first-in-human Phase 1 trial for CD19-positive lymphoma and leukemia.
Selected SAPRO as CRO for the Phase 1 trial, with trial start-up activities underway and expected commencement in early 2026.
Demonstrated potent in vitro activity of CLDN18.2-targeting CAR for ALA-105 program, supporting expansion into solid tumors.
Exercised option to in-license additional CAR targets and iNKT-related technology from Baylor College of Medicine.
Appointed Dr Andrew Nash as Non-Executive Director, with intention to transition to Non-Executive Chairman.
Financial highlights
Cash and cash equivalents at 31 December 2025 totaled $19.4 million.
Quarterly cash outflows from operating activities were $2.5 million, with R&D and staff costs comprising 90% of outflows.
Payments to related parties for the quarter were $154,063, covering director fees and executive salaries.
Estimated 7.6 quarters of funding available based on current cash burn.
Outlook and guidance
Phase 1 clinical trial for ALA-101 expected to commence early 2026, with funding secured to complete enrollment and report initial safety and efficacy data.
Continued progress anticipated in solid tumor program targeting CLDN18.2 and integration of IL-12-TM armouring technology.
Ongoing review of new technologies for potential acquisition to enhance or expand the CAR-iNKT cell platform.
ALA-101 trial start date and key milestones
CLDN18.2 CAR-iNKT in vivo study plans
Baylor DLA progress and new CAR strategic impact
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Arovella Therapeutics earnings date
H1 202626 Feb, 2026
Arovella Therapeutics
Next Arovella Therapeutics earnings date
H1 202626 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Arovella Therapeutics Limited is a biotechnology company specializing in the development of innovative therapies for cancer and other conditions affecting the central nervous system. The company focuses on advancing its proprietary technology platforms to create novel immunotherapies and treatments that target specific disease mechanisms. Arovella's research emphasizes the development of therapies that harness the body's immune system to combat cancer, as well as drug delivery systems to enhance the effectiveness of pharmaceutical compounds. Arovella Therapeutics Limited is headquartered in Sydney, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage